With industries such as technology and consumer discretionary driving, Thursday’s industry Market collapse Follow the President Donald TrumpNew tariffCNBC’s Jim Cramer pointed investors to the same sector that rose after the bursting of the Internet bubble in 2000.

Stocks are aligned on Thursday Dow Jones Leaning nearly 4%, S&P 500 Shed 4.8% Nasdaq Declined by nearly 6%, Russell 2000 Lost 6.4%. Nevertheless, in the Trump tariff era, some companies will do better than others, Cramer said.

“The stock you buy has two important characteristics, and the sentence is encapsulated by this sentence: You want inventory of a domestic company with pricing power and that demand or credit risk is not relaxed, which will slow down.”

Cramer highlights companies in health-related industries such as drug distribution, insurance and medicines. He said medicines specifically offer “slow and steady” growth, which will continue in new markets. The recommended name for Cramer is Cardinal Health,,,,, Bristol Myers squibb and United Health.

Utilities, low-priced retailers, telecommunications and consumer packaged goods will also perform well in slower economic environments, Cramer said. Some of his first choices in these areas are Duke Energy,,,,, TJX,,,,, AT&T and Procter & Gambling.

Financial Technology Company Intercontinental Exchangeand real estate, e.g. Sales volumeCramer added that there is little credit risk and it is also attractive stocks.

While many of these dramas are from the post-Dotcom bubble strategy, Cramer also points to companies that may benefit particularly from Trump’s tariffs. Defense contractors like Boeing and Lockheed Martin Kramer said whether countries that want to appease Trump place big orders to these businesses may see gains.

It’s painful, Kramer said, because it’s away from departments that are soaring in the current market, such as technology and enterprise software. But the April 2000 script re-accounting, he said, limiting investors’ choices.

“I know that investing is more exciting than technology, and technology will have a chance again in the future,” Cramer said. “You know now what it does. I bet the same group will work again.”

Register now Let CNBC Investment Club follow Jim Cramer’s every move in the market.

Disclaimer CNBC Investment Club Charitable Trust holds shares in Bristol-Myers Squibb and TJX.